Search for a command to run...
Ticker: HALEON • | Sector: PHARMACEUTICALS
RevRevenue
✓ GoodRs. 43.11 B
ProfitNet Profit
✓ GoodRs. 6.37 B
EPSEPS
✓ Good₨54.45
ROEROE
✓ Good43.1%
P/EP/E
~ Average13.1x
YieldDividend Yield
✓ Good4.2%
Haleon Pakistan Limited has shown positive revenue growth of 15.9% over the past year. Net income has grown by 39.2% year-over-year. The company maintains a return on equity of 43.1%.
Company profile
HALEON • PHARMACEUTICALS
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
HALEON stock data provided by Ticker Analysts. Prices may be delayed. Data is for informational purposes only.